165 results on '"Severe, Joanne B."'
Search Results
2. Longitudinal study of inflammation and relapse in schizophrenia
3. Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS)
4. Childhood Predictors of Adult Functional Outcomes in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder (MTA)
5. Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results
6. Childhood Factors Affecting Persistence and Desistence of Attention-Deficit/Hyperactivity Disorder Symptoms in Adulthood: Results From the MTA
7. Insomnia and cardiovascular disease risk in schizophrenia
8. Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?
9. Childhood Predictors of Adult Functional Outcomes in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder (MTA)
10. Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results
11. Childhood Factors Affecting Persistence and Desistence of Attention-Deficit/Hyperactivity Disorder Symptoms in Adulthood: Results From the MTA
12. Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial
13. Treatment-Related Changes in Objectively Measured Parenting Behaviors in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder
14. Assessing Medication Effects in the MTA Study Using Neuropsychological Outcomes
15. Comparison of SGA Oral Medications and a Long-Acting Injectable SGA: The PROACTIVE Study
16. Delinquent Behavior and Emerging Substance Use in the MTA at 36 Months: Prevalence, Course, and Treatment Effects
17. Secondary Evaluations of MTA 36-Month Outcomes: Propensity Score and Growth Mixture Model Analyses
18. 3-Year Follow-up of the NIMH MTA Study
19. Nine Months of Multicomponent Behavioral Treatment for ADHD and Effectiveness of MTA Fading Procedures
20. Observed Classroom Behavior of Children with ADHD: Relationship to Gender and Comorbidity
21. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD
22. Which treatment for whom for ADHD? Moderators of treatment response in the MTA
23. Emergency/adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution. (Special Communication)
24. SocioEconomic Status as a moderator of ADHD treatment outcomes
25. Maintenance treatment of schizophrenia: A review of dose reduction and family treatment strategies
26. Medication treatment strategies in the MTA study: relevance to clinicians and researchers
27. Peer-Assessed Outcomes in the Multimodal Treatment Study of Children With Attention Deficit Hyperactivity Disorder
28. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children With ADHD (the MTA): Design Challenges and Choices
29. Relapse and Rehospitalization During Maintenance Treatment of Schizophrenia: The Effects of Dose Reduction and Family Treatment
30. Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis:A Systematic Review, Meta-analysis, and Meta-regression
31. Diagnostic Interview for Genetic Studies: Rationale, Unique Features, and Training
32. Methylphenidate Dosage for Children With ADHD Over Time Under Controlled Conditions: Lessons From the MTA
33. Multimodal Treatment of ADHD in the MTA: An Alternative Outcome Analysis
34. Symptom Profiles in Children With ADHD: Effects of Comorbidity and Gender
35. Clinical Relevance of the Primary Findings of the MTA: Success Rates Based on Severity of ADHD and ODD Symptoms at the End of Treatment
36. ADHD Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups
37. Impairment and Deportment Responses to Different Methylphenidate Doses in Children With ADHD: The MTA Titration Trial
38. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression
39. Mutations in sphingolipid metabolism genes are associated with ADHD.
40. Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis
41. Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS)
42. Efficacy of Drug Treatment for Chronic Schizophrenic Patients
43. Comprehensive Versus Usual Community Care For First Episode Psychosis: Two-Year Outcomes From The NIMH RAISE Early Treatment Program
44. Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program
45. Blood Pressure and Heart Rate in the Multimodal Treatment of Attention Deficit/Hyperactivity Disorder Study Over 10 Years
46. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and Applications for Primary Care Providers
47. Lithium Treatment Moderate-Dose Use Study (LiTMUS) for Bipolar Disorder: A Randomized Comparative Effectiveness Trial of Optimized Personalized Treatment With and Without Lithium
48. Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity.
49. Lithium Treatment Moderate-Dose Use Study (LiTMUS) for Bipolar Disorder: A Randomized Comparative Effectiveness Trial of Optimized Personalized Treatment With and Without Lithium
50. Blood Pressure and Heart Rate Over 10 Years in the Multimodal Treatment Study of Children With ADHD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.